NIMH's Research Domain Criteria (RDoC) domain of negative valence systems (NVS) captures constructs of negative affect such as fear and distress traditionally subsumed under the various internalizing disorders. Through its aims to capture dimensional measures that cut across diagnostic categories and are linked to underlying neurobiological systems, a large number of phenotypic constructs have been proposed as potential research targets. Since "genes" represent a central "unit of analysis" in the RDoC matrix, it is important for studies going forward to apply what is known about the genetics of these phenotypes as well as fill in the gaps of existing knowledge. This article reviews the extant genetic epidemiological data (twin studies, heritability) and molecular genetic association findings for a broad range of putative NVS phenotypic measures. We find that scant genetic epidemiological data is available for experimentally derived measures such as attentional bias, peripheral physiology, or brain-based measures of threat response. The molecular genetic basis of NVS phenotypes is in its infancy, since most studies have focused on a small number of candidate genes selected for putative association to anxiety disorders (ADs). Thus, more research is required to provide a firm understanding of the genetic aspects of anxiety-related NVS constructs. Key words: negative valence; anxiety; twin study; heritability; candidate gene; genome-wide association study
INTRODUCTION
As reviewed elsewhere [Insel et al., 2010; Cuthbert and Insel, 2013] , the National Institute of Mental Health (NIMH)'s strategic plan for research has undergone a paradigm shift regarding the phenotypic outcomes proposed as targets for investigation. Launched in 2009, the Research Domain Criteria (RDoC) project proposes the creation of a new psychiatric research nosology informed by genetics, neurobiology, and behavioral observations rather than clinical diagnoses. RDoC supports a framework for conducting psychiatric research aimed at fundamental brain circuits, physiology, and experimental paradigms that probe dimensions of neural functioning that extend beyond traditional diagnostic categories. Simmons and Quinn [2014] recently summarized the broad questions and possible implications surrounding this paradigm shift for genetics and other biologically based psychopathology research under the NIMH.
In this article, we employ the RDoC framework as a lens through which to review the extant research relevant to understanding the genetics of anxiety. The genetic epidemiology of clinically defined anxiety symptoms and disorders is well studied [Shimada-Sugimoto et al., 2015; Smoller, 2016] ; however, the variants underlying their genetic risk factors are mostly yet to be identified. We summarize genetic epidemiological and molecular genetic studies of dimensional psychological and physiological phenotypes shown to be associated with anxiety disorders (ADs). Many of these phenotypes naturally fall within one or more of the five suggested constructs of the RDoC domain of negative valence systems (NVS): acute threat ("fear"), potential threat ("anxiety"), sustained threat, loss, and frustrative non-reward. As constructed, the NVS domain attempts to reflect an organism's fundamental responses to aversive situations or contexts, such as fear, anxiety, and distress, more traditionally included under the rubrics of anxiety and mood disorders. However, rather than focusing on clinical symptom sets aggregated under diagnostic syndromes, NVS phenotypic expressions may include emotional, biological, or behavioral Neuropsychiatric Genetics responses to these experiences with the ultimate aim of understanding their neural, cellular, and genetic mechanisms.
In the context of this special issue, we exclude loss-related phenotypes, which are more specific to mood disorders. The genetics of biological phenomena such as neural activation and cognitive, emotional, or physiological responses to threat, harm, and frustration are the primary focus of this review. The RDoC matrix is meant to be an evolving, empirically informed framework, so we also consider other dimensional risk markers of anxiety pathology not formally included in NVS such as anxious temperament (but excluding factors of normal personality like neuroticism and harm avoidance). NIMH has referred to such higher-order, more complex constructs as "intermediate phenotypes" [Insel and Cuthbert, 2009] , although this term does not necessarily imply a mediational mechanism (see next paragraph). A guide to the abbreviations used herein for commonly referenced phenotypes and other terms can be found in Table I . A list of gene names corresponding to the gene symbols used throughout this paper can be found in Table II .
Before embarking on this review, one clarification is needed. Most of the measures we review herein have not yet met the necessary criteria to be considered as "endophenotypes." As proposed by Gottesman and Gould [2003] , endophenotypes are measureable traits (e.g., biochemical, neuroanatomical, physiological, or neuropsychological) associated with a disorder that lie closer to the underlying genetic risk variants in the chain of expression leading to manifest pathophysiology. These measures must be associated with the illness (i.e., seen in affected patients), heritable, and co-segregate with the illness in families (i.e., share genetic factors with that of the illness). Some have emphasized the important distinction between endophenotypes for which the genetic factors correlate with those of the disorder ("liability index") versus those that actually mediate the effects of genes on the disorder [Kendler and Neale, 2010] . Most extant studies have not attempted to distinguish these. Other considerations such as experimental design, psychometric properties of the measurement instrument, and data analytic approaches are important but outside the scope of this review. Given the wide variety of measures being investigated by RDoC-inspired research, we focus on the fundamental criterion that a construct is heritable, that is, has a genetic basis. This is traditionally accomplished with genetic epidemiological study designs, primarily twin and family studies. With genome-wide SNP arrays, one can also now estimate "chip heritability" via genome-wide complex trait analysis (GCTA) using all of the common SNP variation on the array present in a sample of "unrelated" subjects to predict the outcome phenotypic measure . We note that there are subtle but important differences between the types of heritability assessable with these two different approaches. Without established heritability of one form or another for a phenotype, there is questionable value in conducting genetic association analyses or estimating genetic covariance with disease outcomes.
In the last few decades of molecular genetic advances leading to wide-spread availability of low-priced, high quality genetic markers, many researchers have "put the cart before the horse," that is, sought molecular genetic signatures for potential endophenotypes for which there are no available estimates of heritability or insight into genetic architecture. Most of these studies investigate a few candidate markers in a narrow range of "usual suspect" genes in neurotransmitter systems (e.g., serotonin, dopamine) that have tentative support, at best, in relation to the etiology of the higher level clinical phenotypes; thus, they provide poor coverage of human genetic variation that could contribute to NVS genetic susceptibility. In addition, candidate gene studies are generally fraught with issues that increase their likelihood of producing both false positives (Type I error) and false negatives (Type II error), such as inconsistent phenotypic assessment between studies, biased selection of a narrow range of genetic variants with little a priori evidence, underpowered samples, failure to correct for multiple testing and ancestry admixture, and lack of replication [Sullivan et al., 2001] .
The aim of this review is to provide a comprehensive overview of the existing genetic studies of dimensional anxiety-related phenotypes. We include genetic epidemiology studies estimating the heritability of these phenotypes and molecular genetic studies that seek to identify specific genes/variants underlying the heritability. Despite the shortcomings noted above that exist across much of the body of molecular work, we attempt to survey the rapidly expanding genetic association literature for NVS phenotypes with emphasis on research conducted, where available, in large, well characterized samples, meta-analyses, and genome-wide association studies (GWAS). In the absence of meta-analyses, we briefly summarize the findings of individual association studies. Detailed reviews of the genetic research on some individual phenotypes, tasks, or of a set of genes (e.g., serotonin system) involved in a particular phenotype have previously been conducted; we will only briefly summarize those data herein. Our goal is to create a single concise source of current information about the heritability and gene identification findings for a broad suite of NVS traits relevant to anxiety/ADs in order to highlight the current state of the field and identify areas in need of further research efforts.
METHOD
We conducted this literature review through a search of the PubMed database by cross-typing two sets of search terms: genetic keywords and NVS phenotype keywords. The genetic keywords were intended to identify both heritability and genetic association studies (e.g., "twin," "heritability," "genetic epidemiology," "gene," "genetic," "polymorphism," "GWAS"). Phenotypic search terms were primarily taken from the RDoC NVS matrix, with auxiliary searches when needed to further flesh out the category or to include different terms used by researchers to describe the same construct. Reference lists of articles resulting from this search were also used to identify additional relevant sources for inclusion, and we conducted a secondary search with each identified phenotype and the keywords "meta-analysis" or "review" to ensure comprehensive coverage of the extant literature.
We group the results of our literature search under specific phenotypes/traits within the four NVS constructs related to ADs: responses to acute threat, responses to potential harm, responses to sustained threat, and frustrative non-reward. Given the high degree of overlap between biological and cognitive systems involved in these constructs, many phenotypes do not fit neatly under a single construct and may, for example, be involved in both appraising potential threats and reacting to acute threats. Where phenotypes did not clearly belong to a single construct, we organize them according to the best fitting category of their specific operationalization in the studies reviewed. Within constructs, we roughly group phenotypes by the units of analysis that make up the columns in the RDoC matrix: functional or structural brain "circuits" associated with ADs, threat-related "physiology," trait-like "behaviors" that predict AD risk, and laboratory "paradigms" that tap into anxiety-relevant NVS constructs. For each of these NVS phenotypes, we summarize heritability estimates and results from candidate gene studies and, where available, GWAS and other molecular genetic approaches. For genetic association studies, we limit our reports to the main effects of variants, given the more tentative nature of gene-by-gene and gene-by-environment interactive effects. We limit our focus to studies of human samples, although we note a few phenotypes for which more extensive genetic research has been conducted in model organisms or for which translational cross-species studies have been reported. As the RDoC constructs are conceptualized as transdiagnostic, dimensional entities, we include studies of both healthy individuals and patients with anxiety-related disorders.
RESULTS
The results are discussed below and summarized in Table III .
Responses to Acute Threat
RDoC defines acute threat as: "Activation of the brain's defensive motivational system to promote behaviors that protect the organism from perceived danger. Normal fear involves a pattern of adaptive responses to conditioned or unconditioned threat stimuli (exteroceptive or interoceptive). Fear can involve internal representations and cognitive processing, and can be modulated by a variety of factors." The NVS construct of acute threat maps on to the domain typically thought of as "fear" and encompasses neurobiological systems responsible for reacting to perceived, immediate danger or threatening stimuli. Acute threat systems mobilize resources (primarily physiological) needed to cope with a threat at hand, in what is commonly known as the fight-or-flight response. Well-characterized phenotypes that fall within this construct include cognitive systems of threat appraisal and conditioned learning and physiological systems of the autonomic nervous system (ANS) and hypothalamic-pituitary-adrenocortical (HPA) axis that underlie the fight-or-flight response. Circuits. Amygdala reactivity. The amygdala is a small, bilateral structure in the temporal lobe that plays a major role in fear and emotional memory Scharinger et al., 2010] . Amygdala reactivity, or the magnitude of response of the amygdala to a stimulus, is typically assessed with a functional magnetic resonance imaging (fMRI) task in which participants are shown pictures of emotional faces (expressing threat-relevant emotions of fear or anger) or non-facial affect-arousing imagery, and the hemodynamic response in the amygdala is measured Sumner et al., 2016] . Following an early report by Hariri et al. [2002] that the 5-HTTLPR functional polymorphism was associated with amygdala reactivity to fearrelevant stimuli, there has been an abundance of genetic association studies investigating the role of 5-HTTPLR and other candidate genetic variants in amygdala reactivity. Despite this, there have been scant genetic epidemiological studies of the heritability of amygdala reactivity. To our knowledge, a single published twin study [Wolfensberger et al., 2008] of 32 MZ twin pairs demonstrated that bilateral amygdala reactivity to emotional faces was higher for concordant pairs at high genetic risk for anxiety/depression than concordant pairs at low genetic risk. However, the extent to which genetic or environmental factors influence amygdala reactivity to threat has not been quantified.
Numerous human candidate gene association studies have been conducted in this area since the original Hariri et.al study, many of which are described in a recent review focusing specifically on the genetics of NVS acute threat systems [Sumner et al., 2016] and prior reviews by Scharinger et al. [2010] and Savitz and Drevets [2009] . We briefly summarize those findings and discuss a few studies not previously covered. The most well-studied genetic variant is the 5-HTTLPR, for which two large meta-analyses [Munaf o et al., 2008; Murphy et al., 2013] have confirmed a small but significant association of the S allele with greater amygdala reactivity. As previously reviewed, other studies have provided additional evidence of the role of the serotonergic system genes (HTR1A, HTR2A, HTR3A, TPH2, and MAOA) in amygdala reactivity. The MAOA VNTR association has been subsequently replicated in a more recent study [Denson et al., 2014 ]. An epigenetic study of the SLC6A4 gene demonstrated that methylation of CpG sites around the transcription start site (indicating potential genetic regulatory effects) was positively correlated (r ¼ 0.07) with left amygdala reactivity even after accounting for 5-HTTPLR genotype [Nikolova et al., 2014] .
The dopaminergic system has also been investigated in several studies. As reviewed by Scharinger et al. [2010] , conflicting evidence has been found for a role of the COMT Val158Met polymorphism (rs4689), with both alleles being reported as the risk allele in different studies. More recent evidence supports the idea that these conflicting findings may be due to sex differences, as Domschke et al., [2012] found a strong association with the Val allele that was evident only in females. Other dopamine-related genes have been associated with amygdala reactivity as well, including the dopamine transporter DAT1/SLC6A3 (9-repeat allele of the VNTR with higher left amygdala activation) [Bergman et al., 2014] , the receptor DRD2 (rs1076560; GG homozygotes with greater left amygdala activation) [Blasi et al., 2009] , and the polymorphism rs1800497 in the DRD2/ANKK1 region (homozygotes for either the A1/A1 or A2/A2 allele with higher amygdala reactivity than heterozygotes) .
A variety of other candidate genes have been investigated for their role in amygdala reactivity in the past few years, although most still require replication. Sumner et al. [2016] and Savits and Drevits [2009] review evidence of association for the BDNF Val66Met polymorphism, with the evidence pointing to greater reactivity in carriers of the Met allele. In other individual studies of genes putatively associated with internalizing disorders, variants in the androgen receptor (AR; trinucleotide repeat), acid-sensing ion channel 1 (ASIC1/ACCN2; rs10875995), fatty acid amide hydrolase (FAAH; rs324420), FK506 binding protein 5 (FKBP5; rs1360780), neuropeptide Y (NPY; rs16147), mineralocorticoid receptor (NR3C2; rs5522), and monoaminergic transmission-related PCLO (rs2522833) genes were significantly associated with amygdala reactivity to emotional faces [Hariri et al., 2009; Manuck et al., 2010; Bogdan et al., 2012; White et al., 2012; Woudstra et al., 2012; Smoller et al., 2014; Holz et al., 2015] . A mouse model evidencing impaired fear after acute administration of a FAAH inhibitor provides translational support for the role of this gene [Gunduz-Cinar et al., 2013] . Another murine-human translational study identified abnormal fear conditioning in a knockout model of the Pet-1 (Fev) gene and found that a SNP within the human ortholog gene PET-1 (rs860573; A allele) was associated with higher amygdala activation as well as psychopathology and "general distress" in humans [Wellman et al., 2007; Wellman et al., 2013] . The adenylate cyclase 7 (ADCY7) gene was identified through an assay of differential gene expression in both mouse and human depression phenotypes, and a polymorphism in this gene (rs1064448; T allele) was associated with amygdala reactivity in two human samples [Joeyen-Waldorf et al., 2012] . Finally, a few studies have used molecular genetic methods beyond candidate gene association. A GWAS of 224 schizophrenia/bipolar disorder (BPD)/psychosis cases and controls identified a single genome-wide significant association in the homeobox gene PHOX2B (rs10014254) with left amygdala reactivity to emotional faces in the combined case-control sample [Ousdal et al., 2012] . However, there was little evidence for association enrichment in the surrounding genomic region, and this association did not replicate in a second sample. Another study compared gene expression in blood mononuclear cells between mood disorder (MDD/BPD) cases and controls and detected 12 differentially expressed genes, of which APBB3, CFD, NFKBIZ, and NUCKS1 expression levels were significantly related to amygdala activation [Savitz et al., 2013] . Arloth et al. [2015] located expression quantitative trait loci (eQTL) underlying glucocorticoid response and used these markers to create polygenic risk scores. These scores predicted blunted amygdala response to angry and sad faces. The lower response was primarily due to an exaggerated reactivity to neutral faces, which suggests that these glucocorticoid response genes might promote an overgeneralized threat response. Gene abbreviations can be found in Table II . Dashes (-) within the table denote a lack of existing studies within the specified phenotype/method. Findings of no significant associations are reported where applicable.
Fronto-limbic connectivity. The critical role of the amygdala in threat appraisal and response, emotion processing, and memory necessitates a great deal of connectivity with numerous other brain structures, especially those in frontal regions that modulate cognitive processing of threatening and emotionally valenced stimuli. Decreased coupling of activation of these regions during threat/ emotion processing, specifically between the amygdala and the anterior cingulate cortex (ACC) or prefrontal cortex (PFC), is theorized to represent a loss of inhibitory cortical control over amygdala reactivity [Scharinger et al., 2011] . The underlying genetic architecture of this fronto-limbic connectivity is not well understood. A single twin study implicated genetic effects on amygdala-ACC and amygdala-PFC coupling during processing of emotional faces, although heritability estimates were not computed [Miskowiak et al., 2015] . The S allele of the 5-HTTLPR and the Met allele of COMT have been linked to changes in functional coupling of the amygdala with the PFC and ACC [see Sumner et al., 2016 for a review], and to lower coupling of the amygdala with an "emotional processing network" (PFC, occipital regions, superior temporal gyrus, and superior temporal sulcus) [Surguladze et al., 2012] . Alexander et al. [2012] also report greater amygdala-hypothalamus coupling in 5-HTTLPR S allele carriers, indicating a role in HPA axis regulation. Won and Ham [2016] discuss two additional studies showing an association between the COMT Met allele and greater amygdala-orbitofrontal cortex connectivity. Scharinger et al. [2011] identify two studies of the role of the MAOA uVNTR on amygdala-ACC coupling but they report opposite directions of effect; a more recent study supported the low-activity variant having greater functional coupling of these regions [Denson et al., 2014] . A variant (rs1625579; T allele) in the microRNA gene MIR137, which affects brain development and neurogenesis, was associated with greater connectivity between the amygdala and frontal regions such as the cingulate and PFC [Mothersill et al., 2014] .
Physiology. Cardiovascular response. Changes in cardiovascular functioning in reaction to stressors are essential to mobilize an adaptive physiological fight-or-flight response. Higher heart rate (HR) and lower heart rate variability (HRV) in response to threat are associated with internalizing psychopathology [Carney et al., 1988; Kemp and Quintana, 2013] . A number of twin studies have found that resting HR and related measures like blood pressure, respiratory sinus arrhythmia, and pre-ejection period are moderately heritable (31-70%) [Ditto, 1993; Van Hulle et al., 2000; Zhang et al., 2004; De Geus et al., 2007] as are their stressresponse component (26-74%, with meta-analysis estimates for HR at 43-45%) [Ditto, 1993; De Geus et al., 2007; Wu et al., 2010] . However, the genetic factors influencing individual differences in resting versus stress-response HR appear to be distinct [Ditto, 1993; Wu et al., 2010] . HRV is also moderately heritable, with estimates from four studies at around 50% [Riese et al., 2007; Wang et al., 2009; Su et al., 2010; Neijts et al., 2014] , although heritability varied for different types of measures such as high versus low frequency spectral power. Unlike HR, 60-81% of the latent genetic influences were shared between resting and stress-response HRV [Wang et al., 2009] , possibly because variation in heart rate intrinsically reflects an organism's changing response to the immediate environment.
Candidate gene studies have primarily been conducted with many of the "usual suspect" neurotransmitter genes as well as genes related to stress response. In the serotonergic system, the 5-HTTLPR S allele has been associated with lower HR and HRV reactivity to stress in two studies [Agorastos et al., 2014; Taylor et al., 2014] and in a third in the context of an interaction with stressful life experiences [Brummett et al., 2011 ]. An additional study found no association with either HR or HRV response [Mueller et al., 2012] , while another found that the L allele was associated with higher basal HR but only in the context of child abuse exposure [Shinozaki et al., 2011] . The MAOA VNTR predicted higher HR in an anxiety-provoking task and a failure to habituate to the task as well as experience of panic attacks and anxiety during the task [Reif et al., 2014] . In the dopaminergic system, the COMT Val158Met polymorphism was associated with a time-dependent effect on HR and HRV in one study [Mueller et al., 2012] ; that is, the Val allele carriers had a greater HR increase, blunted HR recovery, and decreased HRV after a stressor. However, another study showed no main effects of the SNP and evidence that, among MDD patients, it was the Met allele that had lower HRV [Woody et al., 2014] . In the cholinergic system, a large meta-analysis of seven cohorts (N ¼ 6,740) found no evidence for association of genes in the acetylcholine gene pathway with HRV [Riese et al., 2014] .
Stress-response candidate genes thus far implicated in HR response include the glucocorticoid and mineralocorticoid receptors NR3C1 and NR3C2 [DeRijk et al., 2006; van Leeuwen et al., 2011; Taylor et al., 2014] and the adrenergic receptor ADRA2C [Kurnik et al., 2008] . In mouse models, the corticotropin-releasing factor gene Crfr2 had no effect on HR or HRV stress response [Stiedl et al., 2003; Tovote et al., 2005] . Angiotensin-related genes Ace and At1a were associated, respectively, with multiple measures of resting HRV and with decreased HR and blood pressure reactivity to acute stress in a mouse knockout model [Busjahn et al., 1998; Davern et al., 2009] .
Several studies have also examined the BDNF Val66Met variant, with conflicting results reported. The Val allele was associated with higher HR reactivity in one study [Alexander et al., 2010] , which was similar among females in another study, but with the opposite effect in males (Met > Val) [Shalev et al., 2009] . A third study showed no association of BDNF with basal or reactive HR or blood pressure [Colzato et al., 2011] . One further study demonstrated an association between the Met allele and lower high-frequency (parasympathetic nervous system-influenced) HRV and greater low-frequency/high-frequency ratio (sympathetic nervous systeminfluenced) HRV at rest [Yang et al., 2010] . Clearly, there is a need for further efforts to resolve the role of BDNF in cardiovascular functioning. A variant in the related nerve growth factor NGF gene (rs6330; T allele) was associated with lower HRV for men but not women [Chang et al., 2014] . Other candidate genes investigated include the G protein beta-3 subunit (GNB3), which was associated with HR response [Kurnik et al., 2008] , and two G-protein coupled receptors: the oxytocin receptor (OXTR, rs53576, A allele), which showed inconsistent associations with HR-related measures across two studies [Rodrigues et al., 2009; Norman et al., 2012] , and the neuropeptide S receptor NPSR1 (rs324981; T allele), which was associated with higher basal HR but not HR response in females [Domschke et al., 2011] .
Respiratory response. Respiration changes are also an important aspect of the body's mobilization of resources in response to acute threat. Measures of resting pulmonary function are moderately heritable [Ingebrigtsen et al., 2011] , but heritability of the respiratory stress response has not been estimated. One candidate gene study found that a variant in the adenosine receptor ADORA2A (previously implicated in panic and caffeine response) was associated with increased respiratory rate among blood-injection-injury phobia patients exposed to venipuncture [Hohoff et al., 2009] . Tidal volume is another related component of the respiratory response although its genetics are not well-studied; a single murine experiment found that the heritability of tidal volume in response to a stressful task was significantly increased (from 21% to 37%) with early caregiver separation, indicating an environmental augmentation of genetic predisposition [D'Amato et al., 2011] .
Skin conductance response. Skin conductance, or electrodermal activity of the skin's sweat glands, is a marker of ANS activity and physiological arousal. An increase in activity in response to acute threat is known as the skin conductance response (SCR), and higher responses have been reported in patients with ADs [Roth et al., 1990 ]. An early twin study [Lykken et al., 1988] suggested genetic influences on SCR from MZ twin correlations that were nearly twice as high as that of DZ twins; subsequent twin studies have estimated heritability at 43-56% [Tuvblad et al., 2012; Vaidyanathan et al., 2014a] while estimates from a genome-wide measured gene (GCTA) model are somewhat lower, 21-32% [Vaidyanathan et al., 2014a] . A genetically informative factor model of multiple ANS indicators reported that SCR is genetically correlated with other sympathetic nervous system factors such as heart rate [Tuvblad et al., 2010] . One candidate gene study of the 5-HTTLPR and COMT Val158Met polymorphisms found no main effects of either variant, but reported a time-by-genotype interaction for 5-HTTLPR indicative of S allele carriers having greater habituation of the SCR . A recent GWAS in 4,424 individuals found no significant associations with SCR [Vaidyanathan et al., 2014a] .
Alpha-amylase response. Alpha-amylase, measured in the saliva (sAA), is a putative ANS biomarker, with salivary concentrations positively correlating with ANS activation and norepinephrine secretion in response to stressors [Granger et al., 2007] . sAA response to laboratory challenges corresponds to other physiological stress response markers and subjective anxiety ratings [Granger et al., 2007] . A multivariate twin study found that a single set of genetic factors influenced both basal sAA and sAA stress response, with heritability of both between 51% and 62% [Out et al., 2011] . In candidate gene studies, the L allele of the 5-HTTLPR was associated with stronger sAA stress response but also faster recovery in one study of adults [Mueller et al., 2012] . Neither COMT [Mueller et al., 2012] nor BDNF [Tsuru et al., 2014] showed association with sAA levels in other studies.
Cortisol response. Cortisol, a glucocorticoid hormone, is secreted by the HPA axis in response to stress and can be measured in plasma or saliva. Acute cortisol response correlates with ANS/ physiologic stress response and subjective anxiety ratings [Chrousos and Gold, 1992] . Cortisol response to various physical and mental stressors (experimentally constructed via the Trier Social Stress Test, dexamethasone/CRH administration, or the coldpressor test) had negligible heritability estimates in early, small twin studies. However, Federenko et al. [2004] determined that this was likely due to contextual effects, as heritability of cortisol response increased from 32% to 98% with repeated exposure to a stressor task.
HPA axis candidate genes with strong support for a role in the cortisol stress response include CRH, CRHR1, CRHBP, the glucocorticoid/mineralocorticoid receptors NR3C1 and NR3C2, and FKBP5, which moderates the function of the glucocorticoid and mineralocorticoid receptors [DeRijk et al., 2006; Ising et al., 2008; Oberlander et al., 2008; Heim et al., 2009; Tyrka et al., 2009; DeRijk et al., 2011; van Leeuwen et al., 2011; Mahon et al., 2013; Sheikh et al., 2013] . A polygenic risk score constructed from variants in these genes also positively predicted cortisol response curves with stronger effects in females than males [Pagliaccio et al., 2014] . Two studies, including one with over 1,000 participants, found a significant association of the angiotensin converting enzyme (ACE) gene with cortisol response [Baghai et al., 2002; Ancelin et al., 2013] .
Several studies have investigated the role of the 5-HTTLPR in cortisol response, and a recent meta-analysis of 11 samples [Miller et al., 2013] identified a small but significant association of the S allele with greater reactivity, which was also evident in newborns . This effect may be moderated in adults by methylation of the SLC6A4 gene, possibly indicating epigenetic compensatory mechanisms in the stress response [Alexander et al., 2014] . Variants in the serotonin receptor genes HTR2A and HTR2C have also been associated with higher cortisol response [Fiocco et al., 2007; Brummett et al., 2012] .
The BDNF Val66Met polymorphism has had conflicting reports of association, with higher cortisol reactivity in carriers of the Val allele in one study [Alexander et al., 2010] , the Met allele in another [Tsuru et al., 2014] , and neither in a third [Colzato et al., 2011] . Variants in the DRD4 and GABRA6 genes have demonstrated a relationship with cortisol response in one study each [Uhart et al., 2004; Armbruster et al., 2009] , but not in another in which both genes were investigated [Frigerio et al., 2009] . Individual studies requiring replication have also found significant genetic effects on cortisol response in the genes IL-1b, NPSR1, and SLC6A15 [Sasayama et al., 2011; Kumsta et al., 2013; Schuhmacher et al., 2013] .
Startle response. The startle response is a reflexive muscular reaction to an acute unexpected stimulus such as a sudden loud noise or mechanical/tactile stimulation (e.g., strong puff of air to the forehead or neck) that facilitates the fight or flight response [Lang, 1995] . In humans this can be experimentally quantified by measuring the electrical activity produced by the orbicularis oculi muscle during an eye-blink response; murine models often assess whole-body startle reflex. Some evidence indicates that basal/ resting startle is exaggerated in ADs [Mineka et al., 1998 ], although most research has focused on fear-potentiated (FPS) or emotionmodulated startle, which represent an augmented reaction to startle probes administered in the presence of fear-relevant or emotionally valenced stimuli [Vaidyanathan et al., 2009 ].
An early study in 29 pairs of twins found greater correlations for MZ twins than DZ twins in the overall startle response and in the negative and positive emotional modulation of startle, although the sample was too small for formal model testing [Carlson et al., 1997] . A decade later, Anokhin et al. [2007] estimated overall startle heritability at 64% in 123 twin pairs but found no evidence for genetic factors influencing emotional modulation of startle. Recently, a very large (N ¼ 3,323) hybrid twin and molecular genetic study [Vaidyanathan et al., 2014b ] estimated heritability of overall startle across positive, negative, and neutral stimuli at 37-52% using a biometric twin model and at 49% via GCTA using genomewide SNPs; they also found no evidence for significant genetic effects on emotional modulation. In contrast, a mouse model indicated additive (but not dominant) genetic effects impacting FPS, with a heritability of 46% [McCaughran et al., 2000] . Measurement issues may play a role here, given that startle potentiation measures are typically standardized within person prior to analysis to remove inter-individual variability in overall response.
Candidate gene studies have primarily focused on the serotonergic and dopaminergic systems. As reviewed by Sumner et al. [2016] , the 5-HTTLPR S allele has generally been associated with higher overall startle response to neutral and affective imagery but not emotional modulation of the startle response, although its association with fear-(rather than emotion-) potentiated startle was somewhat more consistent. One study found that the S allele was associated with greater FPS only under the threat conditions and not during safety cues, indicating that the conflicting findings may be due to this variant having an effect on defensive reactions rather than fear regulation . A study of the TPH2 gene (rs4570625) found no association for basal startle or FPS . A murine study found that increasing expression of the 5-HT1B receptor in the dorsal raphe nucleus led to attenuated FPS [Clark et al., 2004] .
In the dopaminergic system, conflicting evidence has been found for the COMT Val158Met polymorphism (rs4689), with some reporting an association of the Val allele with higher basal [Comasco et al., 2013] and potentiated startle , others reporting higher basal [Armbruster et al., 2011] and potentiated startle [Norrholm et al., 2013] in carriers of the Met allele, and others reporting no modulation effects [Armbruster et al., 2011; Comasco et al., 2013] . Sumner et al. [2016] reviewed three additional COMT studies with conflicting findings regarding potentiated startle. The DAT1 VNTR 10-repeat allele has also been associated with higher basal/overall but not emotion-modulated startle [Armbruster et al., 2011] . Investigation of other candidate genes BDNF, CRP, and STMN1 did not yield significant basal or potentiated startle associations [Heldt et al., 2007; Brocke et al., 2010; Michopoulos et al., 2015] , though there was some evidence for a gene-by-sex interaction for STMN1 in overall response . The FMR1 gene may play a role in FPS, as individuals carrying a premutation in this gene for the Mendelian fragile X disease lacked a potentiated startle response to fearful face images [Hessl et al., 2007] . Mouse knockout models of the Npy [Karl et al., 2010] and Npsr1 [Zhu et al., 2010 ] genes indicate that these may play a role, as both were associated with a reduced acoustic startle response and related anxiety/arousal phenotypes.
A few studies have also implemented other molecular genetic approaches. Nelson et al. [2014] tested FPS during a threat-ofshock task among individuals of Asian, Caucasian, and Latino ethnicity. They found that Asians had the lowest baseline startle and FPS during unpredictable threat conditions. Furthermore, in order to link these results with possible genetic mechanisms, they correlated baseline startle response with ethnicity principal components derived from ancestry informative genetic markers. They found Asian ancestry was negatively correlated with startle while European ancestry was positively correlated, indicative that genetic variants of lower frequency in Asian ancestry groups may be related to startle response. The first published GWAS of startle response found no genome-wide significant SNP associations for overall or emotion-modulated startle, although post hoc candidate gene and genome-wide gene-based association tests implicated GRIK3 in overall startle and PARP14 in aversive modulation [Vaidyanathan et al., 2014b] . Finally, a genome-wide sequencing study investigating the role of rare variants in physiological endophenotypes found that a greater burden of rare variants in the genes KIF18A and SLC27A6 predicted higher differential startle response to pleasant and aversive imagery, respectively [Vrieze et al., 2014] .
Paradigms. CO 2 challenge. Hypersensitivity to carbon dioxide (CO 2 ), indicated by provocation of panic symptoms when exposed to CO 2 , is a well-replicated marker of genetic liability to ADs, particularly PD [Coryell, 1997] . Paradigms to assess this involve acute administration of CO 2 -enriched air, most commonly either as a single vital capacity inhalation of 35% CO 2 enriched air or a sustained (5-10 min) inhalation of air with 5-7.5% concentration of CO 2 . Virtually all published genetic studies of CO 2 challenge paradigms have used the 35% single-inhalation version (see Amaral et al. [2013] and Battaglia et al. [2014] for reviews). Early twin and family studies found that CO 2 hypersensitivity was familial and showed a higher concordance for CO 2 -provoked panic attacks in MZ than DZ twins [Perna et al., 1996; Bellodi et al., 1998 ]. Larger twin studies have estimated the heritability of CO 2 sensitivity at around 40%, and this genetic risk is shared with separation anxiety and PD [Battaglia et al., 2009; Roberson-Nay et al., 2013] . Some evidence suggests that the acetylcholine system may be involved [Battaglia, 2002] , and one human candidate gene study of the 5-HTTLPR polymorphism found greater CO 2 sensitivity in L carriers than S allele carriers [Schmidt et al., 2000] , although this failed to replicate in another study [Verschoor and Markus, 2012] . Two murine studies, however, have implicated a role of the serotonin system in sensitivity to CO 2 [Li and Nattie, 2008; Puissant et al., 2015] . In another human study, SNPs from multiple candidate genes previously implicated in ADs/traits (CCKBR, SLC6A4, GAD1, COMT, BDNF, TMEM132D, ASIC1, ASIC2, ADCYAP1R1, and FKBP5) were evaluated with respect to respiratory response to a sustained carbon dioxide challenge task [Savage et al., 2015a] . Of these, only the ASIC1 gene was significantly associated with basal respiratory rate and none with respiratory response to the task.
Fear conditioning. Fear conditioning (FC) is the process of associative learning by which a person develops fear toward an evolutionarily neutral stimulus (CSþ) through its repeated pairings with an inherently aversive or threatening unconditioned stimulus (UCS). This is a critical learning mechanism that increases survival likelihood by enhancing avoidance of potential threats, and it is highly conserved across species. FC paradigms pair an aversive electrical shock or loud noise with either a neutral environment (contextual conditioning) or a neutral visual/auditory cue (cued conditioning) and assess the acquired fear response (typically self-report, startle response, or autonomic reactivity like SCR) to the CSþ versus a context or cue that has not been paired with the aversive stimuli, known as the CSÀ. FC paradigms encompass two phases: the acquisition of the conditioned fear association and the extinction of conditioned fear when the CSþ is no longer paired with the UCS. The neural circuitry and cellular signaling pathways underlying FC are well-characterized in rodents, and several reviews on this topic already exist [Pape and Pare, 2010; Briscione et al., 2014; Tovote et al., 2015] . A single twin sample has been used to investigate the heritability of FC using SCR as the physiological measure, which was estimated at 35-45% [Hettema et al., 2003] . Further, in this sample the latent genetic factors influencing FC were distinct from those underlying episodic memory, and the genetic effects on the conditioned SCR were largely distinct from those influencing self-reported fears [Hettema et al., 2008; Fredrikson et al., 2015] .
Much of the candidate gene research on FC has been reviewed in detail elsewhere, and we provide here only a brief overview of these, with a focus on discussing other studies not previously reviewed. Although not entirely consistent, a number of studies across both humans and mice have identified a role of the BDNF Val66Met polymorphism in FC, specifically that the Met allele is related to impaired fear extinction through its putative effects on reducing availability of the BDNF protein product, which has a role in synaptic plasticity (see Lonsdorf and Kalisch [2011] , Erhardt and Spoormaker [2013] , Hartley and Casey [2013] , Johnson and Casey [2015] , and Sumner et al. [2016] for relevant reviews). Lonsdorf and Kalisch [2011] and Bauer [2015] reviewed the evidence for serotonergic gene effects on FC, concluding that 5-HTTLPR S allele carriers express higher levels of conditioned fear and observational fear learning and poorer ability to inhibit fear in the context of the CSÀ or safety cues, although some studies only find this effect when including interactions with other genes or environmental stressors. The serotonin receptor gene HTR1A has also been associated with contextual FC [Baas and Heitland, 2015] . Lonsdorf and Kalisch [2011] and Sumner et al. [2016] also review evidence supporting effects on FC from dopaminergic genes (COMT in extinction resistance and deficits in fear inhibition in the presence of safety cues, DAT1 in extinction, DRD2 with conditioning but not extinction, and no association with DRD4). Other evidence reviewed by Lonsdorf and Kalisch [2011] includes an association of NPSR1 with hypersensitivity to the CSþ and of ADCYAP1R1 with impaired CSþ/CSÀ discrimination, and no FC associations with MAOA or ANKK1. An initial association with ADCYAP1R1 was not supported in two independent samples in a more recent human study [Pohlack et al., 2015] . A review by Stoppel et al. [2006] discusses potential roles of glutamate receptors, ion channels such as ASIC1, genes involved in the CamK and MAPK cell signaling pathways, stress hormones (CRH), neuropeptides (CCK, SST), and cannabinoid receptors. Glucocorticoid genes (CRF receptors, CRHR1, and NR3C1) have received further support in mouse and human studies [Risbrough et al., 2009; Ridder et al., 2012] as have genes involved in the cannabinoid system such as CB1, CB2, and FAAH [Chhatwal et al., 2005; Choi et al., 2012; Heitland et al., 2012; Gunduz-Cinar et al., 2013; Dincheva et al., 2015] .
Fear generalization. Related to FC, fear generalization is the tendency to associate a conditioned fear with objects or events that are similar to the conditioned stimulus. Overgeneralization of the fear response to stimuli that pose no true threat is posited as a maladaptive component of ADs and theorized as the mechanism by which individuals with PD develop widespread agoraphobia. Little genetic research has been conducted on this construct, with a single candidate human study of the ADCYAP1R1 gene (rs2267735, C allele) demonstrating an association with impaired threat/safety stimulus discrimination in a FPS task in females [Ressler et al., 2011] . Knockout studies have identified a role for the mouse genes Gad65 [Bergado-Acosta et al., 2008; Lange et al., 2014] and Gabbr1 [Shaban et al., 2006] , and Grin1 [Vieira et al., 2015] in the biology of fear generalization and discrimination.
Responses to Potential Threat
The RDoC defines potential threat by the following: "Activation of a brain system in which harm may potentially occur but is distant, ambiguous, or low/uncertain in probability, characterized by a pattern of responses such as enhanced risk assessment (vigilance). These responses to low imminence threats are qualitatively different than the high imminence threat behaviors that characterize fear." The potential threat construct is the closest approximation to clinical anxiety (as opposed to phobic fear) within the NVS domain. However the potential threat construct is not as well characterized as the other two threat-related constructs. There are only a few physiology-based phenotypes for sustained threat included in the RDoC matrix, so we have expanded to include others potentially relevant for NVS. While not included in the RDoC NVS matrix, we also summarize findings for specialized constructs of anxious temperament in this section.
Circuits. EEG asymmetry. Asymmetric brain electrical activity theoretically underlies the balance of approach versus avoidance motivation, with right-dominant asymmetry being associated with avoidance [Davidson, 1998; Jacobs et al., 2015] and linked to MDD and negative affect more broadly. This phenotype has been conceptualized as part of the Positive Valence System/reward motivation but is included here because the counterpart to the left-dominant reward motivation phenotype is an individual's predisposition toward increased sensitivity to punishment and avoidance behaviors, which are relevant elements of NVS. A twin study of 123 pairs of female twins estimated the heritability of frontal asymmetry to be 0% and 27% for lateral-frontal and midfrontal regions, respectively [Anokhin et al., 2006] . Two larger twin studies (N ¼ 760-951 individuals) found evidence for slightly higher heritability: 15% (lateral-frontal) and 25% (mid-frontal) [Gao et al., 2009] and 32-37% for overall frontal asymmetry [Smit et al., 2007] , with the study by Smit and colleagues suggesting possible sex differences in heritability. Overall EEG alpha power has stronger genetic effects than asymmetry measures (heritability of 79-85% across all regions) [van Beijsterveldt and van Baal, 2002] . Candidate gene studies have found support for greater right frontal asymmetry (in some regions) in child and adult carriers of the 5-HTTLPR S allele [Bismark et al., 2010; Christou et al., 2016] . Other serotonergic genes have also been studied, with a polymorphism in HTR1A (rs6295; G allele) predicting greater right asymmetry across almost all frontal regions, while a variant in HTR2A was associated with right asymmetry in only one region [Bismark et al., 2010] . There is modest evidence for a role of the BDNF Val66Met SNP (rs6265), with a trend level association between the Met allele and greater right frontal asymmetry in one study of mood disorder cases [Bulgin et al., 2008] .
Physiology. Basal cortisol response. As described in the Acute Threat section, cortisol is a glucocorticoid hormone secreted by the HPA axis in response to stress; however, it also plays a major role in normal metabolism, immune response, and many physiological functions. Higher basal/resting cortisol levels are linked to trait anxiety and internalizing problems, although low basal levels and a blunted cortisol response has been seen in those with MDD or chronic stress, potentially indicative of a down-regulation of the HPA axis after prolonged stress exposure [Chrousos and Gold, 1992] . A meta-analysis of five small twin studies of basal cortisol levels estimated its heritability at 62% [Bartels et al., 2003] , and a large twin study of average daily cortisol levels reported a heritability of 42-48% [Franz et al., 2010] . Candidate gene studies of basal cortisol have alternatively found an association between the 5-HTTLPR and waking cortisol levels and no association between 5-HTTLPR or COMT genotype and cortisol levels assessed at baseline prior to a laboratory stressor . Significant associations have been identified between the BDNF and NR3C2 genes and pre-stressor task cortisol levels [Colzato et al., 2011; DeRijk et al., 2011] . A combined candidate gene/GWA study found significant effects of variants in the FKBP5 candidate gene on average daily cortisol levels although no individual markers reached genome-wide significance [Velders et al., 2011] . However, a GWAS of over 12,000 individuals identified a genome-wide significant association with morning plasma cortisol levels from three partially independent signals in a locus encompassing the SERPINA6 and SERPINA1 genes on chromosome 14, genes which code for corticosteroid-binding globulin and alpha1-antitrypsin, respectively [Bolton et al., 2014] .
Behaviors. Behavioral inhibition. Behavioral inhibition (BI) to the unknown is a temperamental profile characterized as a stable proclivity to be cautious, quiet, and behaviorally restrained in novel situations. Primarily studied in younger children, BI has been identified as a developmental risk factor for social phobia (up to a sevenfold increase in risk [Clauss and Blackford, 2012] ) and possibly panic, other ADs, and depression (reviewed by HirshfeldBecker et al. [2008] ). Several twin studies provide heritability estimates for BI-related phenotypes: around 70% for shyness/ inhibition in pre-school children [Eley et al., 2003 ], 40-60% for withdrawn behavior in a longitudinal study of children ages 3-12 [Hoekstra et al., 2008] , and 45% for a measure of BI in older adults [Mosing et al., 2012] .
Genetic association studies have tested a handful of candidate genes for their potential role in BI (recently reviewed in Clauss et al. [2015] ). One study reported an association of the RGS2 gene, linked to anxious temperament in rodents, with BI and other endophenotypes related to social phobia and introversion [Smoller et al., 2008] , although another study failed to replicate this association [Hettema et al., 2013] . This gene also has reported associations with panic and PTSD. A study of children of parents with PD found an association of the CRH gene with BI [Smoller et al., 2005] . A large German study examined the candidate gene AVPR1A, part of the arginine-vasopressin system which has a role in affiliative behaviors, in relation to the behavioral inhibition system (BIS)/ behavioral activation system (BAS) scales, reporting an association of BIS with SNP rs11174811 [Reuter et al., 2015] . Another German study, conducted in anxiety and depression cases and controls, created a BI proxy score by combining neuroticism and introversion, reporting association of this phenotype with GAD2 [Unschuld et al., 2009] , replicating a prior reported association of BI with this gene [Smoller et al., 2001] . A SNP in an autism risk gene, CNTNAP2, was reported in association with social anxiety and retrospectively reported BI in adults and selective mutism in children [Stein et al., 2011] . Association of the serotonin transporter gene 5-HTTLPR polymorphism with BI was reported in a small sample of Chinese toddlers , while larger studies in US children [Rubin et al., 2013] , Brazilian adolescents [Bortoluzzi et al., 2014] , and Australian adults [Jorm et al., 1998 ] failed to detect an association. The Rubin et al. study, conducted in 394 US children, tested association of 20 polymorphisms in 15 catecholaminergic candidate genes with Withdrawn Behavior Subscale Score (WBS) of the Child Behavior Checklist (CBCL), which combines items indicating inhibition or depression. After correction for age, sex, and multiple testing, they reported significant association of the WBS with two SNPs, one in HTR2A and the other in ADRA2A [Rubin et al., 2013] . To date, no GWAS has examined BI.
Anxiety sensitivity. Anxiety sensitivity (AS) is the fear of the emotional and physiological sensations stemming from anxious arousal. It is thought to arise from beliefs that these sensations have harmful consequences. When individuals high on AS become anxious, they also become alarmed by these arousal-related responses, leading to a further escalation in their level of anxiety [Reiss et al., 1986] . Studies suggest that AS contributes to the risk of developing ADs, particularly panic [Schmidt et al., 2006] . AS is moderately heritable in adults (45%) Stein et al., 1999] , adolescents (47%) , and children (37%) [Eley et al., 2007] . Genetic factors underlying AS predicted the development of anxiety symptoms in childhood [Eley et al., 2007] , supporting its value as an endophenotype.
A handful of candidate genes have been tested for association with AS. One study reported association of CCKBR with AS and cholecystokinin-induced panic [Koszycki et al., 2012] . A German PD research consortium reported association of AS with NPSR1 [Domschke et al., 2011] , CRHR1 , and the gene coding for microRNA hsa-miR-4717-5p, which regulates the gene RGS2 [Hommers et al., 2015] , in conjunction with other PDrelated phenotypes. Such findings are tentative until adequately replicated. One GWAS for AS has been conducted in a sample of 730 adult twin subjects. The authors reported genome-wide significant association for one SNP in the RBFOX1 gene on chromosome 16, with indirect evidence for replication in an independent sample examining AD risk [Davies et al., 2015] .
Trait anxiety. Trait anxiety (TA) is a stable measure of overall stress responsiveness. Individuals with higher TA more likely become anxious when exposed to stress. TA has most often been characterized by the trait subscale of the Spielberger's State-Trait Anxiety Inventory (STAI) [Spielberger et al., 1970] .
The earliest twin studies in UK children report heritability of TA from the Revised Child Manifest Anxiety Scale ranging from 0% to 59% depending upon age and informant [Thapar and McGuffin, 1995] . Similar results were obtained from a US twin sample [Topolski et al., 1999] . Another UK study estimated STAI TA heritability at 31%, with significant genetic correlations with state anxiety [Lau et al., 2006] . A study in US children found lower heritability for TA in early childhood (15%) that increased by late adolescence to 45% [Garcia et al., 2013] . A recent study in Chinese children (ages 9-18) reported heritability estimates of 50-60% for STAI TA [Chen et al., 2015] . We were unable to identify candidate gene studies or GWAS of TA as defined here.
Responses to Sustained Threat
RDoC defines sustained threat as "an aversive emotional state caused by prolonged (i.e., weeks to months) exposure to internal and/or external condition(s), state(s), or stimuli that are adaptive to escape or avoid. The exposure may be actual or anticipated; the changes in affect, cognition, physiology, and behavior caused by sustained threat persist in the absence of the threat, and can be differentiated from those changes evoked by acute threat." Sustained threat differs theoretically from the previous two constructs in that it includes negative emotional and physiological states that are the result of, rather than a proximal response to, threatening or aversive stimuli. This construct is closely connected in some ways to the idea of learned helplessness: psychological or physiological changes within a person that occur when immediate responses to a stressor (such as those recruited by acute threat response systems) are ineffective or impossible to achieve. Phenotypes included in this construct are somewhat more difficult to categorize because the definition of this construct implies a known etiological origin, and it is not always clear whether these psychological and physiological traits are a cause or an effect of psychopathology. However, we review in this section some phenotypes that are putatively altered in response to prolonged stress exposure.
Circuits. Attentional network. Vigilance toward, appraisal of, and response to threat are part of the core conceptualization of NVS traits and behaviors. The attentional network modulates cognitive resources in these domains, and patients with ADs have been shown to have altered functioning of this network. PD, for example, is associated with physiological hyperarousal and increased attention toward perceived or actual threats [Geiger et al., 2014] , while hypervigiliance is a key symptom of PTSD. Although there is overlap with the RDoC "Cognitive Systems" domain, it is included in this review because of the relevance of attentional systems to core NVS elements (and AD correlates) like risk assessment, vigilance, and attentional biases. Brain circuits controlling attention can be reliably parsed into three cohesive anatomical sub-networks: alerting (arousal and response readiness), orienting (directing attention), and executive control (deciding which stimuli to attend/not attend to), each with distinct neural structures and neurotransmitters [Fan et al., 2001] . In a small sample of 52 Chinese twin pairs, each sub-network was found to have genetic influences, with much lower heritability for alerting (18%) and orienting (16%) than for executive control (72%) [Fan et al., 2001] . In a larger follow up in 202 pairs of Caucasian twins aged 6-9, somewhat larger but generally consistent estimates of 32%, 27%, and 55%, respectively, were found, and the latent genetic influences were shared across sub-networks and with working memory .
The norepinephrine-activated alerting network is of particular relevance to NVS as it relates to hypervigilance and attentiveness/ attentional biases toward threat [Geiger et al., 2014] . Genes demonstrating an association with the activation or function of the alerting network include ADRA2A [Green et al., 2008] , NET [Green et al., 2008] , NPSR1 (rs324981) [Neufang et al., 2015] , the NMDA receptor subunit GRIN2B (rs1806201) [Schulz et al., 2012] , CAC-NA1C (rs1006737) [Thimm et al., 2011 ] and, at a trend level only, the dopamine transmitter DAT1 (rs6350) [Konrad et al., 2010] . Other tested variants having no significant associations with the alerting network included TPH2 (rs4570625), ZNF804A (rs1344706), DTNBP1 (rs1018381), and COMT (rs4689) [Reuter et al., 2007; Thimm et al., 2010; Balog et al., 2011] .
Physiology. Error-related negativity (ERN). ERN is a characteristic deflection in the electrical event-related potential (ERP) emitted by the brain within 150 ms after an individual recognizes that they have committed an error. This is typically induced with timed cognitive tasks having a high probability of error, such as Go/ NoGo or flanker tasks where individuals have to identify a visual cue against a difficult discrimination background. As reviewed by Olvet and Hajcak [2008] , there is evidence that higher ERN is associated with, and a putative endophenotype for, depression, anxiety, and internalizing traits, likely through a mechanism of sensitivity to punishment. A single twin study of 274 pairs of adolescents estimated the heritability of ERN at 47% (no sex differences), with high correlations between the genetic factors underlying ERN and the related ERPs of correct response negativity (CRN) and error positivity (Pe) [Anokhin et al., 2008] .
A study of Huntington's disease patients and controls identified a reduced ERN in patients that was correlated with the length of the trinucleotide CAG repeats within their Huntingtin gene, indicative of a potential role of the dopamine system in ERN [Beste et al., 2006] -which is conceptually consistent with the role of dopamine in feedback-related learning. As reviewed by Manoach and Agam [2013] , several genes from the dopaminergic system have been associated with ERN or the related deltaERN measure (difference between the ERN and CRN), with an association of the DAT1 VNTR and conflicting evidence across studies for association of DRD2, DRD4, and COMT. The DRD4 variant rs1800955 (T allele) was associated with increased ERN in one study included in the review [Kramer et al., 2007] , but a more recent study reported an opposite direction of effect [Agam et al., 2014 ]. An additional study of the COMT Val158Met polymorphism supported the association of the Val allele with increased ERN, an effect that was moderated by the acute administration of dopamine . Also discussed by Manoach and Agam [2013] is conflicting evidence for association of the 5-HTTLPR across studies, and evidence from one study each reporting an association between HTR1A (rs6295, G allele) and BDNF (Val allele) and reduced ERN.
Paradigms. Dot probe paradigm. The dot-probe is a visual task that assesses attentional biases by presenting two visual stimuli side-by-side on a screen which are quickly replaced by a target cue whose location the participant must identify. Reaction time to locate the cue reflects whether the participant was attending to the stimulus in the same or different location as the target cue. Attentional biases in relation to negatively valenced or threatening stimuli are commonly reported in AD patients. A small study of 12 pairs of twin children found some initial support (non-significant) for genetic factors underlying attentional orienting to fearful/ threatening emotional faces using this task [Elam et al., 2010] , but two larger studies of 125 and nearly 300 pairs found no evidence of heritability for attentional bias in either children or adults [Rijsdijk et al., 2009; Brown et al., 2013] . Despite this, several candidate gene studies have been conducted with the dot-probe task, with four independent studies finding that carriers of the 5-HTTLPR S allele had greater attentional orienting toward negative emotional stimuli, while L carriers focused their attention away from these [Beevers et al., 2007; Osinsky et al., 2008; Perez-Edgar et al., 2010; Carlson et al., 2012] . In addition, a variant in the FKPB5 gene (rs1360780, T allele) has been linked to greater attentional bias to threat [Fani et al., 2013] , while the BDNF Val66Met polymorphism (rs6265) has shown modest evidence of an indirect effect on attentional threat bias through reductions in white matter tract integrity [Carlson et al., 2014] . One study has demonstrated that variants in the DBH and MAOA genes have an interactive effect, but not individual main effects, on attentional bias toward negative faces [Gong et al., 2013] .
Face emotion processing paradigms. Social cues, particularly facial displays of emotion, are used both to display threat and to convey information about external and potential threats. Emotional (angry/fearful) faces are used in many tasks (e.g., those measuring amygdala threat reactivity), but paradigms specifically investigating the mechanisms underlying face emotional processing typically require participants to correctly identify certain emotions presented in pictures of faces or use eye-tracking software to measure vigilance toward facial cues. Genetic epidemiological studies are lacking, but candidate gene studies have identified a role of the 5-HTTLPR S allele in greater emotion identification accuracy, increased fixation and attentiveness toward facial emotion cues, and a lower likelihood of perceiving neutral faces as happy [Boll and Gamer, 2014; Gohier et al., 2014] . Other studies have identified genetic effects on gaze duration, recognition biases, and neural activation during facial emotion processing from the HTR1A/HTR1B [Mekli et al., 2011] , CB1 [Chakrabarti and Baron-Cohen, 2011] , COMT [Gohier et al., 2014] , OXTR [Puglia et al., 2015] , and TOMM40 [McFarquhar et al., 2014] genes, as well as a set of genes associated with NMDA receptor activation [Mattingsdal et al., 2013] .
Frustrative Non-Reward
RDoC defines this construct as "reactions elicited in response to withdrawal/prevention of reward, that is, by the inability to obtain positive rewards following repeated or sustained efforts." Frustrative non-reward is more tangentially related to ADs having overlap with other psychiatric disorders. Although not specifically listed in the RDoC NVS matrix, we also review irritability as an important transdiagnostic-dimensional phenotype of negative affect related to frustration and aggression.
Behaviors. Reactive aggression. Reactive aggression (RA) is an aggressive response to a perceived threat (the "fight" dimension of the flight or fight response). Only one twin study of RA was identified [Baker et al., 2008] . This study used a US sample of 605 9-year-old twin pairs and found modest heritability estimates for RA in boys (0.38, 95%CI: 0.25-0.49). Girls were found to have no significant genetic influences; instead unique and shared environment likely explained their liability to aggression. In boys, RA measures were moderately correlated with proactive aggression, with a shared genetic correlation of 0.57 (95%CI: 0.38-0.74) 1 [Baker et al., 2008] . We were unable to identify candidate gene studies or GWAS of this phenotype.
Irritability. The DSM defines irritable mood as being "easily annoyed and provoked to anger" and usually refers to frustrative or angry responses to situations/stimuli [American Psychiatric Association, 2013] . Few studies have directly examined the heritability of irritability; most were conducted in the context of related traits (e.g., aggression, depression) [Coccaro et al., 1997; Savage et al., 2015b] or other psychiatric disorders (e.g., bipolar) [Hudziak et al., 2005] . Irritability is usually assessed via behavioral checklists on child self-reports or parents' reports of their child. Available studies suggest that irritability is moderately heritable (around 30%, range 22-51%) [Coccaro et al., 1997; Stringaris et al., 2012; Seroczynski et al., 1999] and potentially developmentally dynamic with differential patterns based on sex. In a Swedish study of 1,310 twin pairs, male irritability exhibited increased heritability from middle childhood to late adolescence, while females exhibited decreasing heritability across the same developmental timespan. We were unable to identify GWAS or candidate gene studies.
DISCUSSION
The current review presented evidence from the existing epidemiological and molecular genetic literature on the genetic etiology of NVS traits, ranging from the biologically proximal brain systems and circuits to peripheral physiology to self-reports of anxious temperament. The wide variety of phenotypes included in this review precludes broad generalizations across the results, but a few consistent points may be noted. First, well-done genetic epidemiology studies for many NVS traits are lacking, especially for the laboratory-based measures that are difficult or expensive to measure on a large scale (e.g., fMRI, physiology). As discussed earlier, measures proposed as endophenotypes need to be heritable and share that heritability with clinical phenotypes ("co-aggregate in relatives") to be relevant for further investigation in gene-finding studies. These various requirements have not been robustly demonstrated for most of the phenotypes reviewed herein. For the phenotypes for which some data are available, the results suggest that the heritability of simpler, biologically based traits are in the same range or modestly higher than that found for their higherlevel disorder-based counterparts. Whether putative endophenotypes are more strongly heritable has been an ongoing subject of debate [Flint and Munafo, 2007] . However, the validity of any such conclusion depends on many factors, such as the power of the sample, the age of the subjects, the instrument used to assess the phenotype, its inherent stability and reliability, and the model used for analysis [Kendler and Neale, 2010] . Furthermore, few twin or family studies have examined multiple NVS measures in the same sample, a requirement to determine their genetic risk structure (covariance), that is, whether they represent the downstream effects of common or distinct sets of underlying genetic factors. Such information can guide how multiple measures may be integrated to optimize the phenotypic targets chosen for studies that seek to discover novel genes and understand the mechanisms by which they produce clinical outcomes.
Second, although a great number of candidate gene association studies have been conducted over the past decade, these have almost exclusively utilized the same few variants in the same limited set of neurotransmitter system genes (e.g., 5-HTTLPR, COMT Val158Met, etc.). Confidence may be cautiously established in a few of these associations that have been consistently replicated or upheld in meta-analyses (e.g., 5-HTTLPR in amygdala reactivity, cortisol and glucocorticoid genes in cortisol response). These "usual suspect" candidates derive from the historical assumption that the etiology of clinical disorders lies in the same biologic systems as those affected by the drugs used to treat them, namely, the monoamine neurotransmitters (serotonin, dopamine, and norepinephrine). We note that this is analogous to studying the genes related to kidney function in order to detect the etiology of heart failure, since diuretics used to relieve its symptoms of fluid overload act in the kidney, not the heart. This has led to an abundance of neuropsychiatric genetic studies aimed at genes in these systems, often limited to one or another putative "functional" polymorphism rather than probing the large range of variation that can affect downstream gene expression. Thus, the available evidence base is both limited and biased, consisting largely of studies of the same few genetic polymorphisms that are those most frequently tested. This continues to occur despite an increasing level of certainty in the psychiatric genetics community that all complex human phenotypes are highly polygenic, influenced by at least hundreds of genetic variants of small effect [Agarwala et al., 2013] , and evidence that the vast majority of genome-wide significant signals from GWAS thus far are novel and located outside of functional protein-coding regions [Maurano et al., 2012] . We acknowledge that the limited choices of suitable candidates available for study drives this folly, as linkage studies have generally not identified more likely candidates for psychopathology, and few results from well-powered GWAS are available to date.
Additional caution is required in the interpretation of candidate gene studies in light of critical reviews of the candidate gene approach [Colhoun et al., 2003; Duncan et al., 2014] , suggesting high rates of false positives due to publication bias, low prior probability of selecting a likely candidate, underpowered samples, and the "winner's curse" of larger than expected effect sizes in the first published study. Indeed, even within one of the few metaanalyses available for experimental NVS traits (association between 5-HTTLPR and amygdala reactivity [Murphy et al., 2013] ) evidence was detected of publication bias and unexpectedly large effect sizes in the published studies. Across the candidate gene studies reported here, the majority had samples of fewer than 200 individuals, especially for neuroimaging protocols, making them likely underpowered based on genetic effect sizes seen by groups such as the Psychiatric Genomics Consortium. Further, many of the reported associations were of marginal significance (P values between 0.01 and 0.05); while this does not negate the possibility of a true association, it also does not inspire confidence.
While the candidate gene approach has many limitations, the more conservative atheoretical GWAS design is also not without difficulties; namely, that it requires very large samples and small P values estimated using strict multiple testing corrections that can be overly stringent. Only a few GWAS of dimensional NVS traits have been published thus far, with no replicated genetic associations identified. Nevertheless, this leaves open a substantial gap in the literature, and recent technological advances and decreases in cost for large-scale molecular genetic studies may stimulate advances in this research area if funding agencies are willing to support them. Limitations due to sample size will likely require meta-analyses across datasets from individual studies like has proven successful in GWAS of clinical disorders; this approach is strongly encouraged and supported by NIMH's RDoC initiative. While novel gene discovery via GWAS is theoretically possible for laboratory-based NVS phenotypes, the effort and expense required to collect such data in sufficiently large samples makes this less plausible. The value of such data might more likely come from the ability to take new candidate genes identified in very large GWAS conducted with cruder, more easily assessed phenotypes (i.e., clinical symptoms or disorders as are being conducted presently) and investigate their mechanistic role in disorder expression through testing them in association with NVS phenotypes.
In conclusion, NVS traits across the range of the RDoC spectrum thus far studied in genetic epidemiological samples are moderately influenced by genetic factors. The first generation of candidate gene and GWAS studies has laid the groundwork to better appreciate and prepare to address the challenges that come along with genetic research of these complex traits. However, this field is still in its infancy; there remains a great deal of work to be done to fully understand the genetic mechanisms underlying these traits including replication and meta-analysis of current findings and GWAS and other innovative study designs to resolve the biological underpinnings of NVS traits and their associations with psychopathology. Their dimensional, possibly endophenotypic nature may lend itself to improved power and reliability for molecular genetic studies, but that is yet to be demonstrated. As recently cautioned by Kozak and Cuthbert [2016] , the level and granularity of current RDoC-formulated constructs may still not map strongly onto molecular genetic signals: "perhaps such narrower constructs (as cognition, emotion, learning, memory, motivation, and perception) are still too broad for practical purposes, and 'explananda' of even smaller grain size might be required for informative crosslevel analyses of biological and psychological phenomena." Thus, the difficulties associated with identifying genes for NVS phenotypes will likely remain as challenging in the RDoC era as they have been for clinical phenotypes.
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